Due Diligence

Technology, market, customers, competitors, business model, regulatory strategy, reimbursement – in the life sciences, you need to go a level deeper to understand the attractiveness and positioning of your target investment. DeciBio can get you there.

Our Experts

David Cavanaugh

David Cavanaugh

Carl Schoellhammer

Carl Schoellhammer

Stephane Budel

Schedule a Call

Related Client Results

All Client Results

Pharma & Biotech

Cell and Gene Therapy Services Landscape Assessment

A top-10 scientific service provider wanted to quantify the size of the CGT services market and understand trends within

No items found.

Pharma & Biotech

Internal Lab Buildout Strategy

A large pharmaceutical company engaged DeciBio to evaluate strategies for an internal build of a lab to support clinical and commercial opportunities in oncology

Voice-of-Customer Research

Due Diligence

Pharma & Biotech

Cell Therapy Market Trends and Revenue Forecast

DeciBio conducted financial projections, valuation, and assisted with messaging to aid client's public listing to NASDAQ

Revenue Projection

Clinical Diagnostics

RNA-based Oncology Biomarker Market Landscape

A cancer diagnostics company wanted to understand the current and future landscape for RNA-based oncology biomarkers, focusing on gene expression profiling (GEP) and rearrangements across medical settings

Voice-of-Customer Research

Competitive Analysis

Biomarker and Diagnostics Strategy

Product Specification Mapping

Clinical Diagnostics

Genetic Testing Company Assessment

A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition

Target Identification

Clinical Diagnostics

IVDR Opportunity Assessment

A top-10 diagnostics company wanted to gauge preparedness and reactions to implementation of IVDR, and how that would impact a potential new product

Voice-of-Customer Research

Precision Medicine is evolving at a rapid pace

Discover how we can help